IRadimed is perceived positively due to its growing ROCE and...

IRadimed is perceived positively due to its growing ROCE and the ability to profitably reinvest capital, which has also started to reap benefits for its shareholders. Regardless of the promising performance, further due diligence is recommended for the company.